Back to catalogue
MPAL
Medpal Ai PLC
380/1000 Overall fit
AI beneficiary 35% 45
Operating leverage 25% 40
Valuation 25% 28
Downside protection 15% 38
First-pass take
Pre-revenue digital health startup (6mo post-IPO) dispensing 70k items/month post-YE. Material going-concern warning reflects pre-profitability, elevated working capital burn, and dilutive ATM raises. AI triage and Eli Lilly GLP-1 pipeline unproven; insufficient evidence of scaled unit economics.
Flags
pre-revenue-at-filingloss-makinggoing-concernearly-stagemicro-capequity-financedfounder-ledworking-capital-intensive